WallStreetZenWallStreetZen

NASDAQ: EPRX
Eupraxia Pharmaceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

EPRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$29.0M
Current Profit Margin
0%

EPRX Return on Equity

Current Company
-579.2%
Current Industry
-63.5%
Current Market
60.5%

Be the first to know when EPRX announces earnings.

EPRX Return on Assets

Current Company
-147.1%
Current Industry
2.9%

EPRX Return on Capital Employed

Current Company
-3,110.9%
Current Industry
19.5%

EPRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TIL$0.00-$145.48M-$156.09M-100.00%N/A
ABCL$38.03M-$143.14M-$146.40M+33.91%N/A
ACST$0.00-$48.89M-$38.77M-100.00%N/A
ABSI$5.72M-$95.46M-$110.57M+29.08%N/A
ADIL$0.00-$5.12M-$5.12MN/AN/A
View Top Biotech Stocks

EPRX earnings dates

Next earnings date
Jun 6, 2024

Eupraxia Pharmaceuticals Earnings & Revenue FAQ

What were EPRX's earnings last quarter?

Eupraxia Pharmaceuticals (NASDAQ: EPRX) reported Q4 2023 earnings per share (EPS) of -$0.13, up 35% year over year. Total Eupraxia Pharmaceuticals earnings for the quarter were -$4.35 million. In the same quarter last year, Eupraxia Pharmaceuticals's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Eupraxia Pharmaceuticals stock.

What was EPRX's earnings growth in the past year?

As of Q2 2024, Eupraxia Pharmaceuticals's earnings has grown year over year. Eupraxia Pharmaceuticals's earnings in the past year totalled -$28.97 million.

What is EPRX's earnings date?

Eupraxia Pharmaceuticals's earnings date is Invalid Date. Add EPRX to your watchlist to be reminded of EPRX's next earnings announcement.

What was EPRX's revenue last quarter?

Eupraxia Pharmaceuticals (NASDAQ: EPRX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Eupraxia Pharmaceuticals's revenue was $0.00.

What was EPRX's revenue growth in the past year?

As of Q2 2024, Eupraxia Pharmaceuticals's revenue has grown null year over year. Eupraxia Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.